Invitrogen™ Human TMEM184C Synthetic Peptide

Ref.: BL-RE-176024Manufacturer ref.: PEP-1047 50 μg
€149.00 excl. VAT

TMEM184C Synthetic Peptide, PEP-1047, from Invitrogen.

Gene ID (Enter)
55751
Species
Human
Purification method
Purified
Accession number
Q9NVA4
Common name
Human TMEM184C
Brand
Invitrogen

TMEM184C Synthetic Peptide, PEP-1047, from Invitrogen.

TMEM184C Synthetic Peptide, PEP-1047, from Invitrogen.

Anaplastic thyroid cancer is one of the most lethal forms of cancer, but the precise carcinogenic mechanism has not been identified. TMEM184C, also known as TMEM34, was identified in a cDNA microarray analysis as being down-regulated in anaplastic thyroid cancers compared to normal thyroid tissues. TMEM184C protein expression was also lower in cell lines derived from these types of cancers compared to that of normal thyroid tissues or cell lines based on other types of thyroid cancers. Furthermore, transfection of TMEM34 into KTA2 cells led to the inhibition of cell growth, suggesting that TMEM184C might act as a tumor suppressor in anaplastic thyroid cancers.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15245049
Specifications
Gene ID (Enter)55751
SpeciesHuman
Purification methodPurified
Accession numberQ9NVA4
Common nameHuman TMEM184C
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TMEM184C
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1047
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.